Acute pulmonary embolism (PE) is not only a serious and potentially life-threatening disease
in the acute phase, in recent years it has become evident that it may also have a major …

Introduction Pulmonary embolism is a common cause of cardiopulmonary mortality and
morbidity worldwide. Survivors of acute pulmonary embolism may experience dyspnea …

Abstract Knowledge regarding the long-term consequences of pulmonary embolism (PE) in
children is limited. This cohort study describes the long-term outcomes of PE in children who …

There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in
morbid obesity after venous thromboembolism (VTE). In this observational study, patients …

Introduction Up to 50% of pulmonary embolism (PE) patients has perfusion defects or
residual vascular obstruction during follow-up despite adequate anticoagulant treatment and …

Funding: The project described in this publication was supported in part by University of
Rochester CTSA award No. KL2 TR001999 (to DL) from the National Center for Advancing …

Introduction Response to anticoagulation varies during management of acute hospitalized
pulmonary embolism. We aimed to study thrombus histology in pulmonary embolism …

People who survive an episode of pulmonary embolism have an increased risk of
developing chronic complications despite curative anticoagulant treatment. The association …

Аннотация Пациенты после перенесенной тромбоэмболии легочной артерии (ТЭЛА)
имеют повышенный риск развития хронических осложнений, несмотря на …

Background Pulmonary embolism (PE) response teams (PERT) have been developed to
improve in-hospital mortality. Identifying intermediate risk PE patients that will progress …